Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P13
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | -201.08% |
| Q4 2025 | 136.49% |
| Q3 2025 | 70.42% |
| Q2 2025 | -138.10% |
| Q1 2025 | 514.62% |
| Q4 2024 | -44.92% |
| Q3 2024 | 710.37% |
| Q2 2024 | 106.36% |
| Q1 2024 | -31.82% |
| Q4 2023 | 23.39% |
| Q3 2023 | -48.89% |
| Q2 2023 | 30.27% |
| Q1 2023 | -35214.29% |
| Q4 2022 | 102.46% |
| Q3 2022 | 8.68% |
| Q2 2022 | -137.47% |
| Q1 2022 | 215.59% |
| Q4 2021 | 250.29% |
| Q3 2021 | 61.62% |
| Q2 2021 | -146.44% |
| Q1 2021 | 13928.57% |
| Q4 2020 | -70.83% |
| Q3 2020 | 101.46% |
| Q2 2020 | -479.68% |
| Q1 2020 | 48.80% |
| Q4 2019 | 147.39% |
| Q3 2019 | -424.79% |
| Q2 2019 | 68.38% |
| Q1 2019 | -234.55% |
| Q4 2018 | -42.83% |
| Q3 2018 | 180.98% |
| Q2 2018 | -786.57% |
| Q1 2018 | 4.29% |
| Q4 2017 | 88.69% |
| Q3 2017 | 74.09% |
| Q2 2017 | -70.52% |
| Q1 2017 | -184.18% |
| Q4 2016 | 80.46% |
| Q3 2016 | 1.02% |
| Q2 2016 | -7.42% |